SecBot SecBot
SECBOTREPLAY Home › Report › TCMD

TCMD · Tactile Medical reported Q3 2026 revenue of $91.9M (+7% YoY), slightly…

TACTILE SYSTEMS TECHNOLOGY INC · 8-K filed Nov 2, 2026 at 16:04 ET

At the news

MIXEDIMPACT 5/10

8-K filed Nov 2, 2026 at 16:04 ET

Tactile Medical reported Q3 2026 revenue of $91.9M (+7% YoY), slightly below the $92.0M consensus, and GAAP EPS of $0.31, below the $0.34 consensus. Net income declined to $7.2M from $8.2M a year ago, and Adjusted EBITDA was essentially flat at $14.3M. The company maintained its full-year revenue guidance of $360M-$366M but raised its Adjusted EBITDA guidance to $50M-$52M from $49M-$51M. The core lymphedema business grew 13% YoY, but airway clearance revenue fell 25% due to DME inventory transition, and operating expenses rose 13%.

  • Q3 2026 total revenue $91.9M, up 7% YoY from $85.8M
  • GAAP diluted EPS $0.31 vs $0.36 in Q3 2025; consensus was $0.34
  • Net income $7.2M vs $8.2M in Q3 2025
  • Adjusted EBITDA $14.3M vs $14.4M in Q3 2025

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access